CIBC Lowers WELL Health Technologies (TSE:WELL) Price Target to C$5.00

WELL Health Technologies (TSE:WELL - Free Report) had its target price reduced by CIBC from C$7.00 to C$5.00 in a report released on Wednesday,BayStreet.CA reports. CIBC currently has a neutral rating on the stock.

A number of other brokerages also recently issued reports on WELL. Raymond James raised their price objective on WELL Health Technologies from C$10.00 to C$11.00 in a research report on Tuesday, December 17th. TD Securities reduced their price target on shares of WELL Health Technologies from C$8.50 to C$7.50 and set a "buy" rating on the stock in a research note on Wednesday, April 16th. Royal Bank of Canada lowered their price objective on shares of WELL Health Technologies from C$8.50 to C$7.50 and set an "outperform" rating for the company in a research report on Monday, March 31st. Finally, Ventum Financial decreased their price target on WELL Health Technologies from C$8.00 to C$7.60 and set a "buy" rating on the stock in a research note on Wednesday, April 16th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of C$8.08.

WELL Health Technologies Trading Down 4.8 %

Shares of TSE WELL traded down C$0.19 during midday trading on Wednesday, reaching C$3.77. 1,110,064 shares of the stock were exchanged, compared to its average volume of 1,005,995. The company has a 50 day simple moving average of C$5.07 and a 200 day simple moving average of C$5.56. The company has a debt-to-equity ratio of 46.79, a quick ratio of 1.02 and a current ratio of 1.14. The stock has a market capitalization of C$942.21 million, a P/E ratio of 12.77, a PEG ratio of -1.93 and a beta of 1.20. WELL Health Technologies has a twelve month low of C$3.48 and a twelve month high of C$7.36.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.